Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial

被引:24
|
作者
Christensen, Thomas D. [1 ]
Maegaard, Marianne
Sorensen, Henrik T.
Hjortdal, Vibeke E.
Hasenkam, J. Michael
机构
[1] Aarhus Univ Hosp, Skejby Sygehus, Dept Cardiothorac & Vasc Surg, DK-8200 Aarhus N, Denmark
[2] Aarhus Univ Hosp, Skejby Sygehus, Inst Clin Med, DK-8200 Aarhus N, Denmark
[3] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus C, Denmark
[4] Aarhus Univ Hosp, Inst Clin Med, DK-8000 Aarhus C, Denmark
关键词
coumarin; anticoagulant; blood coagulation; international normalized ratio;
D O I
10.1016/j.ejim.2005.11.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The efficacy of self-managed oral anticoagulant therapy has been addressed in few randomized, controlled trials, which have provided inconsistent results. The aim of this study was to compare the quality of self-managed oral anticoagulant therapy with conventional management. Methods: This was a pragmatic, open-label, randomized, controlled trial where 100 patients receiving long-term oral anticoagulant therapy referred to a Danish clinic for self-management was randomized to either self-management of oral anticoagulant therapy (including a teaching program of self-management followed by 6 months of self-management) or 6 months of conventional management. The primary endpoint was an intention-to-treat analysis of a composite score combining the variance (median square of the standard deviation) of the International Normalized Ratio (INR) value (using a blinded control sample analyzed monthly by a reference laboratory), death, major complications, or discontinuation from the study. Secondary endpoints - assessed in per-protocol analyses - were the variance of the INR value (using the blinded control sample) and time within therapeutic INR target range using the standard INR values from the coagulometer and laboratory measurement. Results: There was no significant difference in the primary endpoint between the self-management and conventional management groups (composite score 0.16 vs. 0.24, respectively, p = 0.09). Self-management was significantly better (0.16 vs. 0.24, p = 0.003) with regard to the variance in a per-protocol analysis. The difference in time within therapeutic INR target range was not significantly better (78.7% vs. 68.9%, p = 0.14) using self-management. Conclusion: The quality of self-management of oral anticoagulant therapy is at least as good as that provided by conventional management. (C) 2006 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:260 / 266
页数:7
相关论文
共 50 条
  • [1] Comparing self-management of oral anticoagulant therapy with clinic management -: A randomized trial
    Menéndez-Jándula, B
    Souto, JC
    Oliver, A
    Montserrat, I
    Quintana, M
    Glch, I
    Bonfill, X
    Fontcuberta, J
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (01) : 1 - 10
  • [2] Self- versus conventional management of oral anticoagulant therapy: Effects on INR variability and coumarin dose in a randomized controlled trial
    Christensen T.D.
    Maegaard M.
    Sørensen H.T.
    Hjortdal V.E.
    Hasenkam J.M.
    [J]. American Journal of Cardiovascular Drugs, 2007, 7 (3) : 191 - 197
  • [3] Self-versus conventional management of oral anticoagulant therapy
    Christensen, Thomas Decker
    Maegaard, Marianne
    Sorensen, Henrik Toft
    Hjortdal, Vibeke Elisabeth
    Hasenkam, J. Michael
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2007, 7 (03) : 191 - 197
  • [4] Self-Management of Oral Anticoagulant Therapy: A Review
    Thomas D. Christensen
    [J]. Journal of Thrombosis and Thrombolysis, 2004, 18 : 127 - 143
  • [5] Self-management of oral anticoagulant therapy: A review
    Christensen, TD
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2004, 18 (02) : 127 - 143
  • [6] A prospective controlled trial comparing weekly self testing and self dosing with the conventional management of patients on oral anticoagulant therapy
    Watzke, HH
    Forberg, E
    Svolba, G
    Jimenez-Boj, E
    Krinninger, B
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 219 - 219
  • [7] Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands - A randomized clinical trial
    Gadisseur, APA
    Breukink-Engbers, WGM
    van der Meer, FJM
    van den Besselaar, AMH
    Sturk, A
    Rosendaal, FR
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (21) : 2639 - 2646
  • [8] Patient Self-Management of Oral Anticoagulant Therapy: An International Update
    Alan K. Jacobson
    [J]. Journal of Thrombosis and Thrombolysis, 1998, 5 (Suppl 1) : 25 - 28
  • [9] Asthma self-management model: randomized controlled trial
    Olivera, Carolina M. X.
    Vianna, Elcio Oliveira
    Bonizio, Roni C.
    de Menezes, Marcelo B.
    Ferraz, Erica
    Cetlin, Andrea A.
    Valdevite, Laura M.
    Almeida, Gustavo A.
    Araujo, Ana S.
    Simoneti, Christian S.
    de Freitas, Amanda
    Lizzi, Elisangela A.
    Borges, Marcos C.
    de Freitas, Osvaldo
    [J]. HEALTH EDUCATION RESEARCH, 2016, 31 (05) : 639 - 652
  • [10] STROKE SELF-MANAGEMENT: OUTCOMES OF A RANDOMIZED CONTROLLED TRIAL
    Damush, Teresa M.
    Plue, Laurie
    Ofner, Susan
    Yu, Yhangsheng
    Nicholas, Gloria
    Williams, Linda
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2010, 39 : 205 - 205